{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T22:25:01Z","timestamp":1793485501410,"version":"4.5.0"},"reference-count":209,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T00:00:00Z","timestamp":1537401600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"DOI":"10.3389\/fphys.2018.01294","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T10:02:30Z","timestamp":1537437750000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":168,"title":["Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach"],"prefix":"10.3389","volume":"9","author":[{"given":"Clelia","family":"Madeddu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Gramignano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Astara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Demontis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Sanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinicio","family":"Atzeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Macci\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,9,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1038\/sj.bjc.6605255","article-title":"Epoetin-beta treatment in patients with cancer chemotherapy-induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events.","volume":"101","author":"Aapro","year":"2009","journal-title":"Br. J. Cancer."},{"key":"B2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nrrheum.2016.209","article-title":"Leptin in the interplay of inflammation, metabolism and immune system disorders.","volume":"13","author":"Abella","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1182\/asheducation-2008.1.159","article-title":"The anemia of inflammation\/malignancy: mechanisms and management.","volume":"2008","author":"Adamson","year":"2008","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"B4","first-page":"319","article-title":"Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor.","volume":"61","author":"Alvarez-Hernandez","year":"1989","journal-title":"Lab. Invest."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-015-0488-7","article-title":"T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy.","volume":"13","author":"An","year":"2015","journal-title":"World J. Surg. Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: understanding the molecular basis.","volume":"14","author":"Argil\u00e9s","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1200\/JCO.2004.08.119","article-title":"Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial.","volume":"22","author":"Auerbach","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1053\/j.ajkd.2005.06.004","article-title":"Body fat mass and serum leptin levels influence epoetin sensitivity in patients with ESRD.","volume":"46","author":"Axelsson","year":"2005","journal-title":"Am. J. Kidney Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.2146\/ajhp110039","article-title":"Iron replacement therapy in cancer-related anemia.","volume":"68","author":"Baribeault","year":"2011","journal-title":"Am. J. Health Syst. Pharm."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e286","DOI":"10.1016\/j.crohns.2012.10.013","article-title":"Hepcidin is a key mediator of anemia of inflammation in Crohn\u2019s disease.","volume":"7","author":"Basseri","year":"2012","journal-title":"J. Crohns Colitis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1200\/JCO.2006.10.4620","article-title":"Randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoetin alpha administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia.","volume":"26","author":"Bastit","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1517\/14712598.2011.627850","article-title":"A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer.","volume":"11","author":"Bayliss","year":"2011","journal-title":"Expert. Opin. Biol. Ther."},{"key":"B13","first-page":"27","article-title":"Prediction of response to optimize outcome of treatment with erythropoietin.","volume":"25","author":"Beguin","year":"1998","journal-title":"Semin. Oncol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ccell.2014.04.002","article-title":"The physiologic role of erythrocytes in oxygen delivery and implications for blood storage.","volume":"26","author":"Benedik","year":"2014","journal-title":"Crit. Care Nurs. Clin. North Am."},{"key":"B15","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1001\/jama.299.8.914","article-title":"Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia.","volume":"299","author":"Bennett","year":"2008","journal-title":"JAMA"},{"key":"B16","first-page":"297","article-title":"Homeostatic removal of senescent murine erythrocytes by splenic macrophages.","volume":"9","author":"Bennett","year":"1981","journal-title":"Exp. Hematol."},{"key":"B17","first-page":"375","article-title":"Anemia of chronic disorders in systemic autoimmune diseases.","volume":"82","author":"Bertero","year":"1997","journal-title":"Haematologica"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/sj.bjc.6603360","article-title":"Adipose atrophy in cancer cachexia: morphologic and molecular analysis of adipose tissue in tumour-bearing mice.","volume":"95","author":"Bing","year":"2006","journal-title":"Br. J. Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000083128","article-title":"Cancer-related anemia: pathogenesis, prevalence and treatment.","volume":"68","author":"Birgeg\u00e5rd","year":"2005","journal-title":"Oncology"},{"key":"B20","first-page":"616","article-title":"Impact of inflammation on nutrition, iron status, and erythropoietin responsiveness in ESRD patients.","volume":"27","author":"Bistrian","year":"2000","journal-title":"Nephrol. Nurs. J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1634\/theoncologist.9-90005-41","article-title":"rHuEPO and improved treatment outcomes: potential modes of action.","volume":"9","author":"Blackwell","year":"2004","journal-title":"Oncologist"},{"key":"B22","first-page":"1957","article-title":"Epoetin beta (NeoRecormon) corrects anaemia in patients with hormone-refractory prostate cancer and bone metastases.","volume":"24","author":"Bogdanos","year":"2004","journal-title":"Anticancer Res."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007303.pub2","article-title":"Erythropoietin or Darbepoetin for patients with cancer\u2013meta-analysis based on individual patient data.","volume":"3","author":"Bohlius","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"B24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/bjc.2014.171","article-title":"Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data.","volume":"111","author":"Bohlius","year":"2014","journal-title":"Br. J. Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/ncponc0451","article-title":"Cancer-related anemia and recombinant human erythropoietin\u2013an updated overview.","volume":"3","author":"Bohlius","year":"2006","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1139\/apnm-2016-0393","article-title":"Linking skeletal muscle blood flow and metabolism to the limits of human performance.","volume":"42","author":"Boushel","year":"2017","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"B27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0093-7754(01)90205-2","article-title":"Biological basis of anemia.","volume":"28","author":"Bron","year":"2001","journal-title":"Semin. Oncol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1089\/jpm.2010.0143","article-title":"Assessment of fatigue after blood transfusion in palliative care patients: a feasibility study.","volume":"13","author":"Brown","year":"2010","journal-title":"J. Palliat. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1634\/stemcells.2006-0687","article-title":"Erythropoietin receptor expression in non-small cell lung carcinoma: a question of antibody specificity.","volume":"25","author":"Brown","year":"2007","journal-title":"Stem Cells"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/j.bcp.2008.12.018","article-title":"Linking anemia to inflammation and cancer: the crucial role of TNFalpha.","volume":"77","author":"Buck","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1093\/jnen\/62.3.228","article-title":"The pleiotropic effects of erythropoietin in the central nervous system.","volume":"62","author":"Buemi","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1139\/bcb-2015-0066","article-title":"Oxidative stress and damage to erythrocytes in patients with chronic obstructive pulmonary disease\u2013changes in ATPase and acetylcholinesterase activity.","volume":"93","author":"Bukowska","year":"2015","journal-title":"Biochem. Cell. Biol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"E715","DOI":"10.1152\/ajpendo.00153.2015","article-title":"IL-1\u03b2 reciprocally regulates chemokine and insulin secretion in pancreatic \u03b2-cells via NF-\u03baB.","volume":"309","author":"Burke","year":"2015","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1365-2141.2008.07290.x","article-title":"Recent advances in the understanding of inherited sideroblastic anaemia.","volume":"143","author":"Camaschella","year":"2008","journal-title":"Br. J. Haematol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/ijlh.12505","article-title":"The mutual control of iron and erythropoiesis.","volume":"38","author":"Camaschella","year":"2016","journal-title":"Int. J. Lab. Hematol."},{"key":"B36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1042\/cs0870349","article-title":"Anti-tumour necrosis factor-alpha treatment interferes with changes in lipid metabolism in a tumour cachexia model.","volume":"87","author":"Carb\u00f3","year":"1994","journal-title":"Clin. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1002\/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P","article-title":"Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review.","volume":"91","author":"Caro","year":"2001","journal-title":"Cancer"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1001\/jama.2016.9185","article-title":"Clinical practice guidelines from the AABB: red blood cell transfusion thresholds and storage.","volume":"316","author":"Carson","year":"2016","journal-title":"JAMA"},{"key":"B39","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.febslet.2007.11.051","article-title":"TNF-\u03b1 and adipocyte biology.","volume":"582","author":"Cawthorn","year":"2008","journal-title":"FEBS Lett."},{"key":"B40","first-page":"43","article-title":"Factors influencing quality of life in cancer patients: anemia and fatigue.","volume":"25","author":"Cella","year":"1998","journal-title":"Semin. Oncol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1055\/s-2007-989455","article-title":"Does anemia affect outcome after lobectomy or pneumonectomy in early stage lung cancer patients who have not received neo-adjuvant treatment?","volume":"56","author":"Chamogeorgakis","year":"2008","journal-title":"Thorac. Cardiovasc. Surg."},{"key":"B42","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3324\/haematol.2013.091991","article-title":"Heme and erythropoieis: more than a structural role.","volume":"99","author":"Chiabrando","year":"2014","journal-title":"Haematologica"},{"key":"B43","first-page":"2985","article-title":"The importance of growth hormone in the regulation of erythropoiesis, red cell mass, and plasma volume in adults with growth hormone deficiency.","volume":"82","author":"Christ","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aaa5903","article-title":"The mTORC1\/4E-BP pathway coordinates hemoglobin production with L-leucine availability.","volume":"8","author":"Chung","year":"2015","journal-title":"Sci. Signal."},{"key":"B45","doi-asserted-by":"publisher","first-page":"790","DOI":"10.2174\/187152008785914798","article-title":"Tumour hypoxia affects the responsiveness of cancer cells to chemotherapy and promotes cancer progression.","volume":"8","author":"Cosse","year":"2008","journal-title":"Anticancer Agents Med. Chem."},{"key":"B46","doi-asserted-by":"publisher","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-11-0945","article-title":"Interleukin-6 as a therapeutic target in human ovarian cancer.","volume":"17","author":"Coward","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/cncr.10763","article-title":"Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy.","volume":"95","author":"Crawford","year":"2002","journal-title":"Cancer"},{"key":"B48","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.ygyno.2017.05.010","article-title":"Indications for and complications of transfusion and the management of gynecologic malignancies.","volume":"146","author":"Cybulska","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"B49","first-page":"5374","article-title":"Protection of metabolic and exercise capacity in unselected weight-losing cancer patients following treatment with recombinant erythropoietin: a randomized prospective study.","volume":"58","author":"Daneryd","year":"1998","journal-title":"Cancer Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1177\/011542650602100168","article-title":"The origins of cachexia in acute and chronic inflammatory diseases.","volume":"21","author":"Delano","year":"2006","journal-title":"Nutr. Clin. Pract."},{"key":"B51","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.1172\/JCI83054","article-title":"Coordinate expression of heme and globin is essential for effective erythropoiesis.","volume":"125","author":"Doty","year":"2015","journal-title":"J. Clin. Invest."},{"key":"B52","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.stem.2012.01.006","article-title":"Hematopoiesis: a human perspective.","volume":"10","author":"Doulatov","year":"2012","journal-title":"Cell Stem Cell"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.jpainsymman.2003.04.001","article-title":"Anemia at the end of life: prevalence, significance and causes in patients receiving palliative care.","volume":"26","author":"Dunn","year":"2003","journal-title":"J. Pain Symptom Manage."},{"key":"B54","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1182\/blood.V79.8.1987.1987","article-title":"Effect of inflammatory cytokines on hypoxia-induced erythropoietin production.","volume":"79","author":"Faquin","year":"1992","journal-title":"Blood"},{"key":"B55","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus.","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet. Oncol."},{"key":"B56","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1182\/blood.V60.6.1241.1241","article-title":"Erythropoiesis, erythropoietin, and iron.","volume":"60","author":"Finch","year":"1982","journal-title":"Blood"},{"key":"B57","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1046\/j.1525-139x.2000.00104.x","article-title":"The comparative safety of intravenous iron dextran, iron saccharate, and sodium ferric gluconate.","volume":"13","author":"Fishbane","year":"2000","journal-title":"Semin. Dial."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1186\/s12976-015-0015-0","article-title":"Modeling the energetic cost of cancer as a result of altered energy metabolism: implications for cachexia.","volume":"12","author":"Friesen","year":"2015","journal-title":"Theor. Biol. Med. Model."},{"key":"B59","doi-asserted-by":"publisher","first-page":"S187","DOI":"10.1016\/j.ygyno.2005.07.079","article-title":"Pretreatment serum hemoglobin level as a predictive factor of response to neoadjuvant chemotherapy in patients with locally advanced squamous cervical carcinoma: a preliminary report.","volume":"99","author":"Fuso","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1146\/annurev-med-050109-142444","article-title":"Hepcidin and disorders of iron metabolism.","volume":"62","author":"Ganz","year":"2011","journal-title":"Annu. Rev. Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nri3863","article-title":"Iron homeostasis in host defence and inflammation.","volume":"15","author":"Ganz","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1179\/1607845414Y.0000000161","article-title":"Anemia in malignancies: pathogenetic and diagnostic considerations.","volume":"20","author":"Gaspar","year":"2015","journal-title":"Hematology"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/neuro.23.003.2009","article-title":"Neurobiology of inflammation-associated anorexia.","volume":"3","author":"Gautron","year":"2010","journal-title":"Front. Neurosci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1002\/eji.200737401","article-title":"Activities of erythropoietin on tumors: an immunological perspective.","volume":"37","author":"Ghezzi","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1177\/026921639500900405","article-title":"Blood transfusion and its benefits in palliative care.","volume":"9","author":"Gleason","year":"1995","journal-title":"Palliat. Med."},{"key":"B66","first-page":"1","article-title":"FDA orders more changes in ESA label, agents not indicated in curative setting.","volume":"34","author":"Goldberg","year":"2008","journal-title":"Cancer Lett."},{"key":"B67","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.atc.2004.07.004","article-title":"Risks of blood transfusion.","volume":"23","author":"Goodnough","year":"2005","journal-title":"Anesthesiol. Clin. North Am."},{"key":"B68","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1634\/theoncologist.2007-0241","article-title":"Treating anemia of cancer with every-4-week darbepoetin alfa: final efficacy and safety results from a phase II, randomized, double-blind, placebo-controlled study.","volume":"13","author":"Gordon","year":"2008","journal-title":"Oncologist"},{"key":"B69","author":"Grant","year":"2013","journal-title":"Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment: Comparative Effectiveness Update"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/(SICI)1097-0142(19991015)86:8<1528::AID-CNCR20>3.0.CO;2-E","article-title":"The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix.","volume":"86","author":"Grogan","year":"1999","journal-title":"Cancer"},{"key":"B71","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5414\/CN107304","article-title":"Safety, immunogenicity and efficacy of subcutaneous biosimilar epoetin-\u03b1 (HX575) in non-dialysis patients with renal anemia: a multi-center, randomized, double-blind study.","volume":"77","author":"Haag-Weber","year":"2012","journal-title":"Clin. Nephrol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1200\/JOP.0863501","article-title":"Continued regulatory actions affecting the use of erythropoiesis-stimulating agents.","volume":"4","author":"Hagerty","year":"2008","journal-title":"J. Oncol. Pract."},{"key":"B73","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/clpt.1991.210","article-title":"Abraham PA. Comparative pharmacokinetics and pharmacodynamics of epoetin alfa and epoetin beta.","volume":"50","author":"Halstenson","year":"1991","journal-title":"Clin. Pharmacol. Ther."},{"key":"B74","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.transci.2013.12.005","article-title":"Tolerance of anemia: understanding the adaptive physiological mechanisms which promote survival.","volume":"50","author":"Hare","year":"2014","journal-title":"Transfus. Apher. Sci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1213\/ane.0b013e318184cfe9","article-title":"Anemia and cerebral outcomes: many questions, fewer answers.","volume":"107","author":"Hare","year":"2008","journal-title":"Anesth. Analg."},{"key":"B76","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1634\/theoncologist.9-90005-31","article-title":"Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy?","volume":"9","author":"Harrison","year":"2004","journal-title":"Oncologist"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0140-6736(03)14567-9","article-title":"Erythropoietin to treat head and neck cancer patients with anaemia undergoing radio-therapy: randomised, double-blind, placebo-controlled trial.","volume":"362","author":"Henke","year":"2003","journal-title":"Lancet"},{"key":"B78","doi-asserted-by":"publisher","first-page":"4708","DOI":"10.1200\/JCO.2006.06.2737","article-title":"Do erythropoietin receptors on cancer cells explain unexpected clinical findings?","volume":"24","author":"Henke","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1182\/asheducation-2010.1.351","article-title":"Parenteral iron therapy in cancer-associated anemia.","volume":"2010","author":"Henry","year":"2010","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"B80","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1634\/theoncologist.12-2-231","article-title":"Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy.","volume":"12","author":"Henry","year":"2007","journal-title":"Oncologist"},{"key":"B81","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0093-7754(01)90211-8","article-title":"Biological consequences of tumor hypoxia.","volume":"28","author":"H\u00f6ckel","year":"2001","journal-title":"Semin. Oncol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1053\/j.ajkd.2005.02.020","article-title":"High-calorie supplementation increases serum leptin levels and improves response to rHuEPO in long-term hemodialysis patients.","volume":"45","author":"Hung","year":"2005","journal-title":"Am. J. Kidney Dis."},{"key":"B83","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1053\/ajkd.1998.v32.pm9740162","article-title":"Recombinant human growth hormone therapy in malnourished dialysis patients: a randomized controlled study.","volume":"32","author":"Iglesias","year":"1998","journal-title":"Am. J. Kidney Dis."},{"key":"B84","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0024-3205(92)90338-P","article-title":"Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys.","volume":"50","author":"Jelkmann","year":"1992","journal-title":"Life Sci."},{"key":"B85","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1089\/jir.1998.18.555","article-title":"Proinflammatory cytokines lowering erythropoietin production.","volume":"18","author":"Jelkmann","year":"1998","journal-title":"J. Interferon Cytokine Res."},{"key":"B86","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/ajh.21805","article-title":"Biosimilar epoetins and other \u201cfollow-on\u201d biologics: update on the European experiences.","volume":"85","author":"Jelkmann","year":"2010","journal-title":"Am. J. Hematol."},{"key":"B87","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1096\/fj.00-0732fje","article-title":"Induction of HIF-1 alpha in response to hypoxia is instantaneous.","volume":"15","author":"Jewell","year":"2001","journal-title":"FASEB J."},{"key":"B88","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1158\/1078-0432.CCR-07-1872","article-title":"Continuing reassessment of the risks of erythropoiesis-stimulating agents in patients with cancer.","volume":"14","author":"Juneja","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1097\/01.coc.0000264177.66369.18","article-title":"Prognostic significance of blood transfusions in patients with esophageal cancer treated with combined chemoradiotherapy.","volume":"30","author":"Kader","year":"2007","journal-title":"Am. J. Clin. Oncol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1053\/ajkd.2001.29222","article-title":"A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients.","volume":"38","author":"Kalantar-Zadeh","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1002\/eji.200637025","article-title":"Neumann D. Erythropoietin enhances immune responses in mice.","volume":"37","author":"Katz","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/ng.2996","article-title":"Identification of erythroferrone as an erythroid regulator of iron metabolism.","volume":"46","author":"Kautz","year":"2014","journal-title":"Nat. Genet."},{"key":"B93","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1001\/archinte.168.21.2377","article-title":"Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer.","volume":"168","author":"Khorana","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"B94","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1046\/j.1365-2141.1996.d01-1919.x","article-title":"Iron deprivation increases erythropoietin production in vitro, in normal subjects and patients with malignancy.","volume":"95","author":"Kling","year":"1996","journal-title":"Br. J. Haematol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"11S","DOI":"10.1016\/j.amjmed.2003.12.008","article-title":"Prevalence and outcomes of anemia in cancer: a systematic review of the literature.","volume":"116","author":"Knight","year":"2004","journal-title":"Am. J. Med."},{"key":"B96","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1158\/1078-0432.CCR-1161-03","article-title":"T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma.","volume":"10","author":"Lad\u00e1nyi","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"B97","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1182\/blood-2003-03-0953","article-title":"Effect of hepcidin on intestinal iron absorption in mice.","volume":"103","author":"Laftah","year":"2004","journal-title":"Blood"},{"key":"B98","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1089\/ars.2013.5747","article-title":"Oxidative stress and suicidal erythrocyte death.","volume":"21","author":"Lang","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"B99","doi-asserted-by":"publisher","first-page":"5960","DOI":"10.1200\/JCO.2005.06.150","article-title":"Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study.","volume":"23","author":"Leyland\u2013Jones","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"6855","DOI":"10.1158\/1078-0432.CCR-04-0373","article-title":"Effects of recombinant erythropoietin in palliative treatment of unselected cancer patients.","volume":"10","author":"Lindholm","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"B101","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.1182\/blood-2002-08-2459","article-title":"Cytokine-mediated regulation of iron transport in human monocytic cells.","volume":"101","author":"Ludwiczeck","year":"2003","journal-title":"Blood"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.ejca.2009.02.003","article-title":"Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: findings from the Anaemia Cancer Treatment (ACT) study.","volume":"45","author":"Ludwig","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"B103","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0093-7754(01)90206-4","article-title":"Symptomatology of anemia.","volume":"28","author":"Ludwig","year":"2001","journal-title":"Semin. Oncol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.ejca.2004.06.019","article-title":"The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients.","volume":"40","author":"Ludwig","year":"2004","journal-title":"Eur. J. Cancer"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1002\/cncr.20160","article-title":"Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: effects on survival, metabolism, and function.","volume":"100","author":"Lundholm","year":"2004","journal-title":"Cancer"},{"key":"B106","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jpainsymman.2015.04.014","article-title":"A multitargeted treatment approach for anemia and cachexia in metastatic castration-resistant prostate cancer.","volume":"50","author":"Macci\u00f2","year":"","journal-title":"J. Pain Symptom Manage."},{"key":"B107","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.nut.2014.07.016","article-title":"Surprising results of a supportive integrated therapy in myelofibrosis.","volume":"31","author":"Macci\u00f2","year":"","journal-title":"Nutrition"},{"key":"B108","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3324\/haematol.2014.112813","article-title":"The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study.","volume":"100","author":"Macci\u00f2","year":"","journal-title":"Haematologica"},{"key":"B109","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1006\/gyno.1998.4974","article-title":"High serum levels of soluble IL-2 receptor, cytokines, and C reactive protein correlate with impairment of T cell response in patients with advanced epithelial ovarian cancer.","volume":"69","author":"Macci\u00f2","year":"1998","journal-title":"Gynecol. Oncol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cyto.2012.01.015","article-title":"Inflammation and ovarian cancer.","volume":"58","author":"Macci\u00f2","year":"2012","journal-title":"Cytokine"},{"key":"B111","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ygyno.2011.12.435","article-title":"A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: evaluating the impact on metabolic and inflammatory profiles and quality of life.","volume":"124","author":"Macci\u00f2","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1634\/theoncologist.2010-0020","article-title":"Efficacy and safety of oral lactoferrin supplementation in combination with rHuEPO-\u03b2 for the treatment of anemia in advanced cancer patients undergoing chemotherapy: open-label, randomized controlled study.","volume":"15","author":"Macci\u00f2","year":"2010","journal-title":"Oncologist"},{"key":"B113","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.1111\/j.1582-4934.2008.00408.x","article-title":"Interleukin-6 and leptin as markers of energy metabolic changes in advanced ovarian cancer patients.","volume":"13","author":"Macci\u00f2","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"B114","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1182\/blood-2005-01-0160","article-title":"Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer: role of inflammation in cancer-related anemia.","volume":"106","author":"Macci\u00f2","year":"2005","journal-title":"Blood"},{"key":"B115","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1111\/jcmm.12413","article-title":"Role of inflammation and oxidative stress in post-menopausal oestrogen-dependent breast cancer.","volume":"18","author":"Madeddu","year":"2014","journal-title":"J. Cell. Mol. Med."},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.191551","article-title":"Microenvironmental M1 tumor-associated macrophage polarization influences cancer-related anemia in advanced ovarian cancer: key role of Interleukin-6.","author":"Madeddu","year":"2018","journal-title":"Haematologica"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.2217\/fon.15.195","article-title":"Muscle wasting as main evidence of energy impairment in cancer cachexia: future therapeutic approaches.","author":"Madeddu","year":"2015","journal-title":"Future Oncol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1007\/s00109-003-0476-1","article-title":"Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress.","volume":"81","author":"Mantovani","year":"2003","journal-title":"J. Mol. Med."},{"key":"B119","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s001090100234","article-title":"Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites.","volume":"79","author":"Mantovani","year":"2001","journal-title":"J. Mol. Med."},{"key":"B120","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/s001090000137","article-title":"Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites.","volume":"78","author":"Mantovani","year":"2000","journal-title":"J. Mol. Med."},{"key":"B121","doi-asserted-by":"publisher","first-page":"32398","DOI":"10.18632\/oncotarget.16132","article-title":"A polymorphism at IGF1 locus is associated with anemia.","volume":"8","author":"Marini","year":"2017","journal-title":"Oncotarget"},{"key":"B122","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1200\/JCO.2014.56.1894","article-title":"Diagnostic criteria for the classification of cancer-associated weight loss.","volume":"33","author":"Martin","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1091\/mbc.e02-07-0422","article-title":"Global transcription analysis of Krebs tricarboxylic acid cycle mutants reveals an alternating pattern of gene expression and effects on hypoxic and oxidative genes.","volume":"14","author":"McCammon","year":"2003","journal-title":"Mol. Biol. Cell."},{"key":"B124","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.bcmd.2013.09.004","article-title":"Interleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cells.","volume":"52","author":"McCranor","year":"2014","journal-title":"Blood Cells Mol. Dis."},{"key":"B125","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/MCO.0b013e32832a7902","article-title":"Systemic inflammation, nutritional status and survival in patients with cancer.","volume":"12","author":"McMillan","year":"2009","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"B126","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/stem.5530130105","article-title":"Pathogenesis of the anemia of chronic disease: a cytokine-mediated anemia.","volume":"13","author":"Means","year":"1995","journal-title":"Stem Cells"},{"key":"B127","first-page":"116","article-title":"Recent developments in the anemia of chronic disease.","volume":"2","author":"Means","year":"2003","journal-title":"Curr. Hematol. Rep."},{"key":"B128","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1089\/jpm.2008.0139","article-title":"Effects of red blood transfusion on anemia-related symptoms in patients with cancer.","volume":"12","author":"Mercadante","year":"2009","journal-title":"J. Palliat. Med."},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009624.pub2","article-title":"The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis stimulating agents.","volume":"2","author":"Mhaskar","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"B130","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000438976","article-title":"Biosimilar epoetin zeta in oncology and haematology: development and experience following 6 years of use.","volume":"135","author":"Michallet","year":"2016","journal-title":"Acta Haematol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1200\/JCO.2007.10.7805","article-title":"Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer.","volume":"26","author":"Miller","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"37472","DOI":"10.1074\/jbc.M112.358911","article-title":"Sustained submicromolar H2O2 levels induce hepcidin via signal transducer and activator of transcription 3 (STAT3).","volume":"287","author":"Millonig","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B133","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1093\/ndt\/gfq690","article-title":"Association between the malnutrition-inflammation score and post-transplant anaemia.","volume":"26","author":"Molnar","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"B134","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/MOH.0b013e328329905c","article-title":"Erythroid glucose transporters.","volume":"16","author":"Montel-Hagen","year":"2009","journal-title":"Curr. Opin. Hematol."},{"key":"B135","first-page":"3495","article-title":"Evaluation of epoetin supplemented with oral iron in patients with solid malignancies and chronic anemia not receiving anticancer treatment.","volume":"25","author":"Mystakidou","year":"2005","journal-title":"Anticancer Res."},{"key":"B136","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.exphem.2005.05.003","article-title":"Pivotal role of peroxisome proliferator-activated receptor gamma (PPARgamma) in regulation of erythroid progenitor cell proliferation and differentiation.","volume":"33","author":"Nagasawa","year":"2005","journal-title":"Exp. Hematol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.micinf.2011.10.005","article-title":"The pleiotropic effects of erythropoietin in infection and inflammation.","volume":"14","author":"Nairz","year":"2012","journal-title":"Microbes Infect."},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aab1203","article-title":"Amino acid uptake in erythropoiesis.","volume":"8","author":"Nathan","year":"2015","journal-title":"Sci. Signal."},{"key":"B139","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.amjms.2016.10.009","article-title":"Erythropoietin and nonhematopoietic effects.","volume":"353","author":"Nekoui","year":"2017","journal-title":"Am. J. Med. Sci."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1172\/JCI200420945","article-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin.","volume":"113","author":"Nemeth","year":"2004","journal-title":"J. Clin. Invest."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1345\/aph.1L231","article-title":"Tumor progression associated with erythropoiesis-stimulating agents.","volume":"42","author":"Newland","year":"2008","journal-title":"Ann. Pharmacother."},{"key":"B142","doi-asserted-by":"publisher","first-page":"4596","DOI":"10.1073\/pnas.072632499","article-title":"Severe iron deficiency anemia in transgenic mice expressing liver hepcidin.","volume":"99","author":"Nicolas","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B143","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1182\/blood.V86.3.900.900","article-title":"Recombinant human interleukin-6 induces a rapid and reversible anemia in cancer patients.","volume":"86","author":"Nieken","year":"1995","journal-title":"Blood"},{"key":"B144","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1600-0609.2004.00374.x","article-title":"Insulin-like growth factor-1 is a predictor of blood haemoglobin concentration in 70-yr-old subjects.","volume":"74","author":"Nilsson-Ehle","year":"2005","journal-title":"Eur. J. Haematol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/(SICI)1097-0142(19980815)83:4<726::AID-CNCR14>3.0.CO;2-U","article-title":"The relationship of pretreatment serum hemoglobin level to the survival of epithelial ovarian carcinoma patients: a prospective review.","volume":"83","author":"Obermair","year":"1998","journal-title":"Cancer"},{"key":"B146","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/MOH.0000000000000234","article-title":"Metabolic regulation of hematopoietic stem cell commitment and erythroid differentiation.","volume":"23","author":"Oburoglu","year":"2016","journal-title":"Curr. Opin. Hematol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.stem.2014.06.002","article-title":"Glucose and glutamine metabolism regulate human hematopoietic stem cell lineage specification.","volume":"15","author":"Oburoglu","year":"2014","journal-title":"Cell Stem Cell"},{"key":"B148","doi-asserted-by":"crossref","first-page":"534","DOI":"10.5604\/17322693.1005677","article-title":"Oxidative stress modulates the organization of erythrocyte membrane cytoskeleton.","volume":"66","author":"Olszewska","year":"2012","journal-title":"Postepy Hig. Med. Dosw."},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00003","article-title":"Primitive and definitive erythropoiesis in mammals.","volume":"5","author":"Palis","year":"2014","journal-title":"Front. Physiol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.lfs.2016.11.033","article-title":"TNF-\u03b1 and cancer cachexia: molecular insights and clinical implications.","volume":"170","author":"Patel","year":"2017","journal-title":"Life Sci."},{"key":"B151","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.cca.2011.12.008","article-title":"Integrative role of neuropeptides and cytokines in cancer anorexia-cachexia syndrome.","volume":"413","author":"Patra","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1200\/JCO.2007.12.2051","article-title":"Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha.","volume":"26","author":"Pedrazzoli","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2016.3","article-title":"Understanding cachexia as a cancer metabolism syndrome.","volume":"5","author":"Porporato","year":"2016","journal-title":"Oncogenesis"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009007.pub2","article-title":"Blood transfusions for anaemia in patients with advanced cancer.","volume":"2","author":"Preston","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.3324\/haematol.2011.053397","article-title":"Late stage erythroid precursor production is impaired in mice with chronic inflammation.","volume":"97","author":"Prince","year":"2012","journal-title":"Haematologica"},{"key":"B157","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ctrv.2006.04.008","article-title":"Cancer-related anaemia management in the 21st century.","volume":"32","author":"Pronzato","year":"2006","journal-title":"Cancer Treat. Rev."},{"key":"B158","doi-asserted-by":"publisher","first-page":"4126","DOI":"10.1200\/JCO.2001.19.21.4126","article-title":"Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy.","volume":"19","author":"Quirt","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1093\/ndt\/gfs368","article-title":"Association of malnutrition-inflammation complex and responsiveness to erythropoiesis-stimulating agents in long-term hemodialysis patients.","volume":"28","author":"Rattanasompattikul","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"B160","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.autrev.2012.03.003","article-title":"Iron levels in polarized macrophages: regulation of immunity and autoimmunity.","volume":"11","author":"Recalcati","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"B161","doi-asserted-by":"publisher","first-page":"H2206","DOI":"10.1152\/ajpheart.00348.2009","article-title":"Structural adaptation of microvessel diameters in response to metabolic stimuli: where are the oxygen sensors?","volume":"297","author":"Reglin","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.biochi.2016.03.012","article-title":"Pathological and molecular mechanisms underlying resistance to recombinant human erythropoietin therapy in the remnant kidney rat model of chronic kidney disease associated anemia.","volume":"125","author":"Ribeiro","year":"2016","journal-title":"Biochimie"},{"key":"B163","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1182\/blood-2010-08-300541","article-title":"American Society of Hematology\/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer.","volume":"116","author":"Rizzo","year":"2010","journal-title":"Blood"},{"key":"B164","author":"Rodgers","year":"2017","journal-title":"NCCN. Cancer- and Chemotherapy-Induced Anemia, Version 2.2017"},{"key":"B165","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0891-5849(03)00071-6","article-title":"The antioxidant status during maturation of reticulocytes to erythrocytes in type 2 diabetics.","volume":"35","author":"Sailaja","year":"2003","journal-title":"Free. Radic. Biol. Med."},{"key":"B166","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.cytogfr.2006.09.006","article-title":"Waste management - cytokines, growth factors and cachexia.","volume":"17","author":"Saini","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1210\/endo-126-2-1288","article-title":"Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro.","volume":"126","author":"Sandler","year":"1990","journal-title":"Endocrinology"},{"key":"B168","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s12094-008-0237-2","article-title":"Predictors of response to erythropoiesis-stimulating agents (ESA) in cancer patients: the role of baseline serum epoetin level.","volume":"10","author":"Sanz Ortiz","year":"2008","journal-title":"Clin. Transl. Oncol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"18975","DOI":"10.1074\/jbc.R115.650150","article-title":"Regulation of iron metabolism by hepcidin during conditions of inflammation.","volume":"290","author":"Schmidt","year":"2015","journal-title":"J. Biol. Chem."},{"key":"B170","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.2146\/ajhp060601","article-title":"Anemia in patients with cancer: incidence, causes, impact, management, and use of treatment guidelines and protocols.","volume":"64","author":"Schwartz","year":"2007","journal-title":"Am. J. Health Syst. Pharm."},{"key":"B171","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1172\/JCI11223","article-title":"Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1.","volume":"106","author":"Semenza","year":"2000","journal-title":"J. Clin. Invest."},{"key":"B172","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S0037-1963(01)90125-8","article-title":"The negative impact of anemia on radiotherapy and chemoradiation outcomes.","volume":"38","author":"Shasha","year":"2001","journal-title":"Semin. Hematol."},{"key":"B173","doi-asserted-by":"publisher","first-page":"28","DOI":"10.5468\/ogs.2014.57.1.28","article-title":"Prognostic value of pretreatment hemoglobin level in patients with early cervical cancer.","volume":"57","author":"Shin","year":"2014","journal-title":"Obstet. Gynecol. Sci."},{"key":"B174","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/ejh.12402","article-title":"Hepcidin in tumor-related iron deficiency anemia and tumor-related anemia of chronic disease: pathogenic mechanisms and diagnosis.","volume":"94","author":"Shu","year":"2014","journal-title":"Eur. J. Haematol."},{"key":"B175","first-page":"130","article-title":"Practice parameter for the use of red blood cell transfusions: developed by the Red Blood Cell Administration Practice Guideline Development Task Force of the College of American Pathologists.","volume":"122","author":"Simon","year":"1998","journal-title":"Arch. Pathol. Lab. Med."},{"key":"B176","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"Correction of anemia with epoetin alfa in chronic kidney disease.","volume":"355","author":"Singh","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"B177","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/nri1685","article-title":"Regulation of immune cells by local-tissue oxygen tension: HIF1\u03b1 and adenosine receptors.","volume":"5","author":"Sitkovsky","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"B178","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1200\/JCO.2007.14.2885","article-title":"Darbepoetin alpha for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study.","volume":"26","author":"Smith","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/S0140-6736(00)02249-2","article-title":"The blood in systemic disorders.","volume":"355","author":"Spivak","year":"2000","journal-title":"Lancet"},{"key":"B180","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrc1648","article-title":"The anaemia of cancer: death by a thousand cuts.","volume":"5","author":"Spivak","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"B181","first-page":"421","article-title":"Iron and the anemia of chronic disease: vindication for the Non-essential role of iron supplementation.","volume":"25","author":"Spivak","year":"2011","journal-title":"Oncology"},{"key":"B182","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1634\/theoncologist.2009-S1-43","article-title":"Anemia management in oncology and hematology.","volume":"14","author":"Spivak","year":"2009","journal-title":"Oncologist"},{"key":"B183","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1200\/JCO.2007.15.3874","article-title":"Is anemia of cancer different from chemotherapy-induced anemia?","volume":"26","author":"Steensma","year":"2008","journal-title":"Clin. Oncol."},{"key":"B184","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1200\/JCO.2010.30.3644","article-title":"Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia.","volume":"29","author":"Steensma","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"B185","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1046\/j.1365-2141.1998.00521.x","article-title":"Epoetin alfa and beta differ in their erythropoietin isoform compositions and biological properties.","volume":"100","author":"Storring","year":"1998","journal-title":"Br. J. Haematol."},{"key":"B186","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1172\/JCI115767","article-title":"Evidence for the involvement of interleukin 6 in experimental cancer cachexia.","volume":"89","author":"Strassmann","year":"1992","journal-title":"J. Clin. Invest."},{"key":"B187","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1160\/TH10-06-0379","article-title":"Low insulin-like growth factor-1 levels are associated with anaemia in adult non-diabetic subjects.","volume":"105","author":"Succurro","year":"2011","journal-title":"Thromb. Haemost."},{"key":"B188","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1053\/ajkd.2002.33918","article-title":"Factors contributing to higher hematocrit levels in hemodialysis patients not receiving recombinant human erythropoietin.","volume":"40","author":"Takeda","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"B189","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/annonc\/mdh178","article-title":"Use of red blood cell transfusion in palliative care services: it is still up to date or is cancer-related anemia controlled better with erythropoietic agents?","volume":"15","author":"Tanneberger","year":"2004","journal-title":"Ann. Oncol."},{"key":"B190","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1038\/sj.ki.4490858","article-title":"Erythropoietin hyporesponsiveness: from iron deficiency to iron overload.","volume":"69","author":"Tarng","year":"1999","journal-title":"Kidney Int. Suppl."},{"key":"B191","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0093-7754(01)90215-5","article-title":"The effect of hemoglobin level on radiotherapy outcomes: the Canadian experience.","volume":"28","author":"Thomas","year":"2001","journal-title":"Semin. Oncol."},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003407.pub5","article-title":"Erythropoietin or darbepoetin for patients with cancer.","volume":"12","author":"Tonia","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"B193","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1182\/blood.V99.10.3505","article-title":"Regulation of ferritin genes and protein.","volume":"99","author":"Torti","year":"2002","journal-title":"Blood"},{"key":"B194","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1097\/01.CCM.0000159849.94750.51","article-title":"Transfusion-related acute lung injury: definition and review.","volume":"33","author":"Toy","year":"2005","journal-title":"Crit. Care Med."},{"key":"B195","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/jjco\/hyn151","article-title":"Weekly administration of epoetin beta for chemotherapy-induced anemia in cancer patients: results of a multicenter, phase III, randomized, double-blind, placebo-controlled study.","volume":"39","author":"Tsuboi","year":"2009","journal-title":"Jpn. J. Clin. Oncol."},{"key":"B196","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1152\/ajpregu.00411.2013","article-title":"Differential HIF and NOS responses to acute anemia: defining organ-specific hemoglobin thresholds for tissue hypoxia.","volume":"307","author":"Tsui","year":"2014","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"B197","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1749-6632.1998.tb09582.x","article-title":"Mechanisms of hypothalamic-pituitary-adrenal axis stimulation by immune signals in the adult rat.","volume":"840","author":"Turnbull","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B198","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1182\/blood.V90.9.3438","article-title":"Leptin stimulates the proliferation of murine myelocytic and primitive hematopoietic progenitor cells.","volume":"90","author":"Umemoto","year":"1997","journal-title":"Blood"},{"key":"B199","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation.","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"B200","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1245\/s10434-007-9502-9","article-title":"Anemia and transfusions in patients undergoing surgery for cancer.","volume":"15","author":"Weber","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"B201","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMra041809","article-title":"Anemia of chronic disease.","volume":"352","author":"Weiss","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"B202","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.2215\/CJN.01490506","article-title":"Assessing iron status: beyond serum ferritin and transferrin saturation.","volume":"1","author":"Wish","year":"2006","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B203","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1152\/jappl.1982.53.5.1299","article-title":"Effect of increased oxygen affinity and anemia on cardiac output and its distribution.","volume":"53","author":"Woodson","year":"1982","journal-title":"J. Appl. Physiol."},{"key":"B204","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1200\/JCO.2006.07.1514","article-title":"Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia.","volume":"25","author":"Wright","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1038\/srep12291","article-title":"Hypoxia-induced autophagy mediates cisplatin resistance in lung cancer cells.","volume":"5","author":"Wu","year":"2015","journal-title":"Sci. Rep."},{"key":"B206","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.2147\/OTT.S158206","article-title":"The role of HIF-1\u03b1 in chemo-\/radioresistant tumors.","volume":"11","author":"Xia","year":"2018","journal-title":"Onco Targets Ther."},{"key":"B207","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1002\/cam4.1233","article-title":"Combined prognostic value of pretreatment anemia and cervical node necrosis in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: a large-scale retrospective study.","volume":"6","author":"Zhang","year":"2017","journal-title":"Cancer Med."},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-844","article-title":"Impact of preoperative anemia on relapse and survival in breast cancer patients.","volume":"14","author":"Zhang","year":"2014","journal-title":"BMC Cancer"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136268","article-title":"Association of pretreatment anemia with pathological response and survival of breast cancer patients treated with neoadjuvant chemotherapy: a population-based study.","volume":"10","author":"Zhu","year":"2015","journal-title":"PLoS One"}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphys.2018.01294\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T09:13:28Z","timestamp":1571908408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphys.2018.01294\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,20]]},"references-count":209,"alternative-id":["10.3389\/fphys.2018.01294"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2018.01294","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,20]]},"article-number":"1294"}}